The Effects Of Relaxation Training In Women With Primary Dysmenorrhea
Primary Purpose
Primary Dysmenorrhea
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Relaxation training
No intervention
Sponsored by
About this trial
This is an interventional treatment trial for Primary Dysmenorrhea
Eligibility Criteria
Inclusion Criteria:
- Women with primary dysmenorrhea complaint according to the Primary Dysmenorrhea Consensus Guide,
- Over 18 years of age,
- Having a mean pain intensity of moderate and higher according to the Visual Analogue Scale in the last 6 months,
- Having a regular menstrual cycle (28±7 days),
- Volunteered to participate in the study.
Exclusion Criteria:
- Having a pathological history and radiological findings pointing to secondary dysmenorrhea,
- Using oral contraceptives/antidepressants at least 6 months,
- Receiving hormone therapy,
- Undergoing pelvic surgery,
- Pregnant,
- Giving birth,
- Using an intrauterine device,
- Having neurological, orthopedic and/or rheumatological diseases
- Having a psychiatric disease,
- Having a history of malignancy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Relaxation group
Control group
Arm Description
Jacobson progressive relaxation training will be applied
No intervention will be applied
Outcomes
Primary Outcome Measures
Menstrual pain intensity
Menstrual pain intensity will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point "0" = "no pain", while "10" = "unbearable pain". Individuals will be asked to mark on a 10 cm straight line according to the level of pain they feel. Pain intensity will be recorded by measuring the distance between the beginning of the line and the marked place.
Secondary Outcome Measures
Menstrual symptoms
Menstrual symptoms will be measured with the menstrual symptom questionnaire. Menstrual Symptom Questionnaire is a 24-item self-report scale and each item is scored between 1 (never) and 5 (always). An increase in the mean score indicates an increase in the severity of menstrual symptoms. The total score is 120 points.
Impacts of academic/work performance
Impacts of academic/work performance will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point "0"= means "my work/school performance is not affected in any way", while "10"= means "my work/school performance is greatly affected"
Impacts of life quality
Impacts of life quality will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point "0" = "my quality of life is not affected in any way", while "10" = "my quality of life is greatly affected". Individuals will be asked to mark on a 10 cm straight line according to the quality of life they think.
Impacts of social activity
Impacts of social activity will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point "0" = "my social activity is not affected in any way", while "10" = "my social activity is greatly affected". Individuals will be asked to mark on a 10 cm straight line according to the social activity they think.
Anxiety level
Anxiety level will be assessed with the Spielberger State Trait Anxiety Inventory. This inventory is a 40-item self-report inventory designed to measure both state anxiety section (current feelings of apprehension, worry, etc.) and trait anxiety section (continuous feelings of apprehension, worry, etc.). Each section is scored on four levels of anxiety intensity from 1="not at all" to 4="very much" and with a sum score between 20 and 80. A higher total score indicates more severe anxiety level.
Full Information
NCT ID
NCT05328869
First Posted
April 7, 2022
Last Updated
April 7, 2022
Sponsor
Ankara Yildirim Beyazıt University
1. Study Identification
Unique Protocol Identification Number
NCT05328869
Brief Title
The Effects Of Relaxation Training In Women With Primary Dysmenorrhea
Official Title
The Effects Of Relaxation Training In Women With Primary Dysmenorrhea
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
May 15, 2022 (Anticipated)
Primary Completion Date
October 15, 2022 (Anticipated)
Study Completion Date
December 15, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ankara Yildirim Beyazıt University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The aim of this study was to investigate the effects of relaxation training on menstrual pain severity, menstrual symptoms, impact of quality of life, impact of work/academic performance, impact of social activity level and anxiety level in women with primary dysmenorrhea (PD) complaints.
Detailed Description
PD is the cramping pain that comes before or during a menstrual period. Relaxation training contributes to the reduction of stress and pain. Thus, there is a need to investigate the effects of relaxation training in dysmenorrhea.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Primary Dysmenorrhea
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Relaxation group
Arm Type
Experimental
Arm Description
Jacobson progressive relaxation training will be applied
Arm Title
Control group
Arm Type
Other
Arm Description
No intervention will be applied
Intervention Type
Other
Intervention Name(s)
Relaxation training
Intervention Description
Relaxation training will be performed under the supervision of a physiotherapist. The training is carried out from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins
Intervention Type
Other
Intervention Name(s)
No intervention
Intervention Description
No intervention will be applied. The natural process will be followed from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins
Primary Outcome Measure Information:
Title
Menstrual pain intensity
Description
Menstrual pain intensity will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point "0" = "no pain", while "10" = "unbearable pain". Individuals will be asked to mark on a 10 cm straight line according to the level of pain they feel. Pain intensity will be recorded by measuring the distance between the beginning of the line and the marked place.
Time Frame
change from baseline at an average of 2 weeks
Secondary Outcome Measure Information:
Title
Menstrual symptoms
Description
Menstrual symptoms will be measured with the menstrual symptom questionnaire. Menstrual Symptom Questionnaire is a 24-item self-report scale and each item is scored between 1 (never) and 5 (always). An increase in the mean score indicates an increase in the severity of menstrual symptoms. The total score is 120 points.
Time Frame
change from baseline at an average of 2 weeks
Title
Impacts of academic/work performance
Description
Impacts of academic/work performance will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point "0"= means "my work/school performance is not affected in any way", while "10"= means "my work/school performance is greatly affected"
Time Frame
change from baseline at an average of 2 weeks
Title
Impacts of life quality
Description
Impacts of life quality will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point "0" = "my quality of life is not affected in any way", while "10" = "my quality of life is greatly affected". Individuals will be asked to mark on a 10 cm straight line according to the quality of life they think.
Time Frame
change from baseline at an average of 2 weeks
Title
Impacts of social activity
Description
Impacts of social activity will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point "0" = "my social activity is not affected in any way", while "10" = "my social activity is greatly affected". Individuals will be asked to mark on a 10 cm straight line according to the social activity they think.
Time Frame
change from baseline at an average of 2 weeks
Title
Anxiety level
Description
Anxiety level will be assessed with the Spielberger State Trait Anxiety Inventory. This inventory is a 40-item self-report inventory designed to measure both state anxiety section (current feelings of apprehension, worry, etc.) and trait anxiety section (continuous feelings of apprehension, worry, etc.). Each section is scored on four levels of anxiety intensity from 1="not at all" to 4="very much" and with a sum score between 20 and 80. A higher total score indicates more severe anxiety level.
Time Frame
change from baseline at an average of 2 weeks
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Primary dysmenorrhea is a gynecological problem that can be seen in most women.
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Women with primary dysmenorrhea complaint according to the Primary Dysmenorrhea Consensus Guide,
Over 18 years of age,
Having a mean pain intensity of moderate and higher according to the Visual Analogue Scale in the last 6 months,
Having a regular menstrual cycle (28±7 days),
Volunteered to participate in the study.
Exclusion Criteria:
Having a pathological history and radiological findings pointing to secondary dysmenorrhea,
Using oral contraceptives/antidepressants at least 6 months,
Receiving hormone therapy,
Undergoing pelvic surgery,
Pregnant,
Giving birth,
Using an intrauterine device,
Having neurological, orthopedic and/or rheumatological diseases
Having a psychiatric disease,
Having a history of malignancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Seyda Toprak Celenay
Phone
+90312 906 1000
Email
sydtoprak@hotmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Seyda Toprak Celenay
Organizational Affiliation
Ankara Yildirim Beyazıt University
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
The Effects Of Relaxation Training In Women With Primary Dysmenorrhea
We'll reach out to this number within 24 hrs